Literature DB >> 21749855

Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: insight into the ganglioside binding mechanism.

Nipawan Nuemket1, Yoshikazu Tanaka, Kentaro Tsukamoto, Takao Tsuji, Keiji Nakamura, Shunji Kozaki, Min Yao, Isao Tanaka.   

Abstract

Clostridium botulinum type D strain OFD05, which produces the D/C mosaic neurotoxin, was isolated from cattle killed by the recent botulism outbreak in Japan. The D/C mosaic neurotoxin is the most toxic of the botulinum neurotoxins (BoNT) characterized to date. Here, we determined the crystal structure of the receptor binding domain of BoNT from strain OFD05 in complex with 3'-sialyllactose at a resolution of 3.0Å. In the structure, an electron density derived from the 3'-sialyllactose was confirmed at the cleft in the C-terminal subdomain. Alanine site-directed mutagenesis showed the significant contribution of the residues surrounding the cleft to ganglioside recognition. In addition, a loop adjoining the cleft also plays an important role in ganglioside recognition. In contrast, little effect was observed when the residues located around the surface previously identified as the protein receptor binding site in other BoNTs were substituted. The results of cell binding analysis of the mutants were significantly correlated with the ganglioside binding properties. Based on these observations, a cell binding mechanism of BoNT from strain OFD05 is proposed, which involves cooperative contribution of two ganglioside binding sites.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749855     DOI: 10.1016/j.bbrc.2011.06.173

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.

Authors:  Keiji Nakamura; Tomoko Kohda; Yuto Shibata; Kentaro Tsukamoto; Hideyuki Arimitsu; Mitsunori Hayashi; Masafumi Mukamoto; Nobuyuki Sasakawa; Shunji Kozaki
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  Development and Validation of a New Reliable Method for the Diagnosis of Avian Botulism.

Authors:  Caroline Le Maréchal; Sandra Rouxel; Valentine Ballan; Emmanuelle Houard; Typhaine Poezevara; Marie-Hélène Bayon-Auboyer; Rozenn Souillard; Hervé Morvan; Marie-Agnès Baudouard; Cédric Woudstra; Christelle Mazuet; Sophie Le Bouquin; Patrick Fach; Michel Popoff; Marianne Chemaly
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

4.  Botulinum Neurotoxins: Mechanism of Action.

Authors:  O Rossetto; M Pirazzini; F Fabris; C Montecucco
Journal:  Handb Exp Pharmacol       Date:  2021

5.  Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.

Authors:  Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

6.  Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.

Authors:  Lisheng Peng; Ronnie P-A Berntsson; William H Tepp; Rose M Pitkin; Eric A Johnson; Pål Stenmark; Min Dong
Journal:  J Cell Sci       Date:  2012-03-27       Impact factor: 5.285

7.  Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Authors:  Ronnie Per-Arne Berntsson; Lisheng Peng; Linda Marie Svensson; Min Dong; Pål Stenmark
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

8.  Structure of dual receptor binding to botulinum neurotoxin B.

Authors:  Ronnie P-A Berntsson; Lisheng Peng; Min Dong; Pål Stenmark
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546

10.  A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency.

Authors:  Daniel Stern; Jasmin Weisemann; Alexander Le Blanc; Laura von Berg; Stefan Mahrhold; Janett Piesker; Michael Laue; Peter B Luppa; Martin Bernhard Dorner; Brigitte Gertrud Dorner; Andreas Rummel
Journal:  PLoS Pathog       Date:  2018-05-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.